Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Instuitional Investor - Flagship Ventures Management, Inc.

Fund Profile
Filing Period:
Fund Name: Flagship Ventures Management, Inc.
Portfolio Value $298,998,000
Fund Holdings Sector Distribution
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value (x$1000) % Port
1.
Seres Therapeutics Inc
12,682,876 $203,433 68.03%
2.
Syros Pharmaceuticals Inc
3,204,437 $47,169 15.77%
3.
Editas Medicine Inc
1,674,435 $40,203 13.44%
4.
T2 Biosystems Inc
1,950,583 $8,193 2.74%